BIOMARIN PHARMACEUTICAL INC Interest Expense
BIOMARIN PHARMACEUTICAL INC (BMRN) reported Interest Expense of $60.73 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2026-08-06
- BIOMARIN PHARMACEUTICAL INC interest expense for the quarter ending 2026-06-30 was $60.73M, a 2444.11% increase year-over-year.
- BIOMARIN PHARMACEUTICAL INC interest expense for the quarter ending 2026-03-31 was $9.57M, a 300.96% increase year-over-year.
- BIOMARIN PHARMACEUTICAL INC interest expense for the quarter ending 2025-06-30 was $2.39M.
- BIOMARIN PHARMACEUTICAL INC interest expense for the quarter ending 2025-03-31 was $2.39M, a 32.70% decline year-over-year.
- BIOMARIN PHARMACEUTICAL INC interest expense for fiscal 2023 was $17.34M, a 8.55% increase from fiscal 2022.
- BIOMARIN PHARMACEUTICAL INC interest expense for fiscal 2022 was $15.97M, a 4.13% increase from fiscal 2021.
- BIOMARIN PHARMACEUTICAL INC interest expense for fiscal 2021 was $15.34M, a 47.67% decline from fiscal 2020.
- BIOMARIN PHARMACEUTICAL INC interest expense for fiscal 2020 was $29.31M, a 24.93% increase from fiscal 2019.
| Period end | Interest Expense 3 month | Interest Expense 3 month as first filed | Interest Expense 6 month | Interest Expense 6 month as first filed | Interest Expense 9 month | Interest Expense 9 month as first filed | Interest Expense 12 month | Interest Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $60.73M 10-Q · filed 2026-08-06 | $75.62M 10-Q · filed 2026-08-06 | ||||||
| 2026-03-31 | $9.57M 10-Q · filed 2026-05-05 | |||||||
| 2025-06-30 | $2.39M 10-Q · filed 2026-08-06 | $4.77M 10-Q · filed 2026-08-06 | ||||||
| 2025-03-31 | $2.39M 10-Q · filed 2026-05-05 | |||||||
| 2024-03-31 | $3.55M 10-Q · filed 2024-04-26 | $9.64M derived: sum of 2 quarters · filed 2024-04-26 | $13.42M derived: sum of 3 quarters · filed 2024-04-26 | $17.18M derived: sum of 4 quarters · filed 2024-04-26 | ||||
| 2023-12-31 | $6.10M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $9.88M derived: sum of 2 quarters · filed 2024-02-26 | $13.63M derived: sum of 3 quarters · filed 2024-02-26 | $17.34M 10-K · filed 2024-02-26 | ||||
| 2023-09-30 | $3.78M 10-Q · filed 2023-11-02 | $7.53M derived: sum of 2 quarters · filed 2023-11-02 | $11.24M 10-Q · filed 2023-11-02 | $14.86M derived: sum of 4 quarters · filed 2024-04-26 | ||||
| 2023-06-30 | $3.75M 10-Q · filed 2023-08-02 | $7.46M 10-Q · filed 2023-08-02 | $11.08M derived: sum of 3 quarters · filed 2024-04-26 | $15.76M derived: sum of 4 quarters · filed 2024-04-26 | ||||
| 2023-03-31 | $3.70M 10-Q · filed 2024-04-26 | $7.33M derived: sum of 2 quarters · filed 2024-04-26 | $12.01M derived: sum of 3 quarters · filed 2024-04-26 | $15.87M derived: sum of 4 quarters · filed 2024-04-26 | ||||
| 2022-12-31 | $3.63M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $8.30M derived: sum of 2 quarters · filed 2024-02-26 | $12.16M derived: sum of 3 quarters · filed 2024-02-26 | $15.97M 10-K · filed 2024-02-26 | ||||
| 2022-09-30 | $4.68M 10-Q · filed 2023-11-02 | $8.54M derived: sum of 2 quarters · filed 2023-11-02 | $12.34M 10-Q · filed 2023-11-02 | $16.19M derived: sum of 4 quarters · filed 2024-02-26 | ||||
| 2022-06-30 | $3.86M 10-Q · filed 2023-08-02 | $7.67M 10-Q · filed 2023-08-02 | $11.51M derived: sum of 3 quarters · filed 2024-02-26 | $15.38M derived: sum of 4 quarters · filed 2024-02-26 | ||||
| 2022-03-31 | $3.81M 10-Q · filed 2023-04-28 | $7.65M derived: sum of 2 quarters · filed 2024-02-26 | $11.52M derived: sum of 3 quarters · filed 2024-02-26 | $15.34M derived: sum of 4 quarters · filed 2024-02-26 | ||||
| 2021-12-31 | $3.85M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $7.72M derived: sum of 2 quarters · filed 2024-02-26 | $11.53M derived: sum of 3 quarters · filed 2024-02-26 | $15.34M 10-K · filed 2024-02-26 | ||||
| 2021-09-30 | $3.87M 10-Q · filed 2022-10-28 | $7.69M derived: sum of 2 quarters · filed 2022-10-28 | $11.49M 10-Q · filed 2022-10-28 | $16.24M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2021-06-30 | $3.82M 10-Q · filed 2022-08-04 | $7.62M 10-Q · filed 2022-08-04 | $12.37M derived: sum of 3 quarters · filed 2023-02-27 | $21.97M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2021-03-31 | $3.80M 10-Q · filed 2022-04-29 | $8.55M derived: sum of 2 quarters · filed 2023-02-27 | $18.15M derived: sum of 3 quarters · filed 2023-02-27 | $26.20M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2020-12-31 | $4.75M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $14.35M derived: sum of 2 quarters · filed 2023-02-27 | $22.39M derived: sum of 3 quarters · filed 2023-02-27 | $29.31M 10-K · filed 2023-02-27 | ||||
| 2020-09-30 | $9.60M 10-Q · filed 2021-10-29 | $17.64M derived: sum of 2 quarters · filed 2021-10-29 | $24.56M 10-Q · filed 2021-10-29 | $31.49M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2020-06-30 | $8.05M 10-Q · filed 2021-07-30 | $14.96M 10-Q · filed 2021-07-30 | $21.89M derived: sum of 3 quarters · filed 2022-02-25 | $24.83M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2020-03-31 | $6.92M 10-Q · filed 2021-04-30 | $13.85M derived: sum of 2 quarters · filed 2022-02-25 | $16.78M derived: sum of 3 quarters · filed 2022-02-25 | $23.65M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2019-12-31 | $6.93M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $9.87M derived: sum of 2 quarters · filed 2022-02-25 | $16.73M derived: sum of 3 quarters · filed 2022-02-25 | $23.46M 10-K · filed 2022-02-25 | ||||
| 2019-09-30 | $2.94M 10-Q · filed 2020-11-06 | $9.80M derived: sum of 2 quarters · filed 2020-11-06 | $16.53M 10-Q · filed 2020-11-06 | $24.28M derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2019-06-30 | $6.87M 10-Q · filed 2020-08-05 | $13.59M 10-Q · filed 2020-08-05 | $21.34M derived: sum of 3 quarters · filed 2021-02-26 | $33.47M derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2019-03-31 | $6.73M 10-Q · filed 2020-05-01 | $14.47M derived: sum of 2 quarters · filed 2021-02-26 | $26.60M derived: sum of 3 quarters · filed 2021-02-26 | $38.83M derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2018-12-31 | $7.75M derived: 10-K 12 month − 10-Q/A 9 month · filed 2021-02-26 | $19.88M derived: sum of 2 quarters · filed 2021-02-26 | $32.10M derived: sum of 3 quarters · filed 2021-02-26 | $43.66M 10-K · filed 2021-02-26 | ||||
| 2018-09-30 | $12.13M 10-Q/A · filed 2019-11-04 | $24.36M derived: sum of 2 quarters · filed 2019-11-04 | $35.92M 10-Q/A · filed 2019-11-04 | $47.58M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-06-30 | $12.22M 10-Q · filed 2019-08-02 | $23.79M 10-Q · filed 2019-08-02 | $35.45M derived: sum of 3 quarters · filed 2020-02-27 | $46.34M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-03-31 | $11.56M 10-Q · filed 2019-04-29 | $23.23M derived: sum of 2 quarters · filed 2020-02-27 | $34.11M derived: sum of 3 quarters · filed 2020-02-27 | $44.15M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2017-12-31 | $11.66M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $22.55M derived: sum of 2 quarters · filed 2020-02-27 | $32.59M derived: sum of 3 quarters · filed 2020-02-27 | $42.71M 10-K · filed 2020-02-27 | ||||
| 2017-09-30 | $10.88M 10-Q · filed 2018-10-26 | $20.92M derived: sum of 2 quarters · filed 2018-10-26 | $31.04M 10-Q · filed 2018-10-26 | $40.77M derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2017-06-30 | $10.04M 10-Q · filed 2018-08-03 | $20.16M 10-Q · filed 2018-08-03 | $29.89M derived: sum of 3 quarters · filed 2019-02-28 | $39.87M derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2017-03-31 | $10.12M 10-Q · filed 2018-04-27 | $19.85M derived: sum of 2 quarters · filed 2019-02-28 | $29.83M derived: sum of 3 quarters · filed 2019-02-28 | $39.77M derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2016-12-31 | $9.73M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $19.71M derived: sum of 2 quarters · filed 2019-02-28 | $29.66M derived: sum of 3 quarters · filed 2019-02-28 | $39.50M 10-K · filed 2019-02-28 | ||||
| 2016-09-30 | $9.98M 10-Q · filed 2017-10-31 | $19.92M derived: sum of 2 quarters · filed 2017-10-31 | $29.77M 10-Q · filed 2017-10-31 | $39.10M derived: sum of 4 quarters · filed 2018-02-26 | ||||
| 2016-06-30 | $9.94M 10-Q · filed 2017-08-02 | $19.79M 10-Q · filed 2017-08-02 | $29.12M derived: sum of 3 quarters · filed 2018-02-26 | $38.57M derived: sum of 4 quarters · filed 2018-02-26 | ||||
| 2016-03-31 | $9.84M 10-Q · filed 2017-05-04 | $19.18M derived: sum of 2 quarters · filed 2018-02-26 | $28.62M derived: sum of 3 quarters · filed 2018-02-26 | $38.63M derived: sum of 4 quarters · filed 2018-02-26 | ||||
| 2015-12-31 | $9.33M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $18.78M derived: sum of 2 quarters · filed 2018-02-26 | $28.78M derived: sum of 3 quarters · filed 2018-02-26 | $38.24M 10-K · filed 2018-02-26 | ||||
| 2015-09-30 | $9.45M 10-Q · filed 2016-11-03 | $19.45M derived: sum of 2 quarters · filed 2016-11-03 | $28.91M 10-Q · filed 2016-11-03 | $38.11M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-06-30 | $10.00M 10-Q · filed 2016-08-08 | $19.46M 10-Q · filed 2016-08-08 | $28.66M derived: sum of 3 quarters · filed 2017-02-27 | $37.78M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-03-31 | $9.46M 10-Q · filed 2016-05-02 | $18.66M derived: sum of 2 quarters · filed 2017-02-27 | $27.78M derived: sum of 3 quarters · filed 2017-02-27 | $37.00M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2014-12-31 | $9.20M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $18.32M derived: sum of 2 quarters · filed 2017-02-27 | $27.54M derived: sum of 3 quarters · filed 2017-02-27 | $36.64M 10-K · filed 2017-02-27 | ||||
| 2014-09-30 | $9.12M 10-Q · filed 2015-11-02 | $18.34M derived: sum of 2 quarters · filed 2015-11-02 | $27.45M 10-Q · filed 2015-11-02 | $35.04M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-06-30 | $9.22M 10-Q · filed 2015-08-05 | $18.33M 10-Q · filed 2015-08-05 | $25.92M derived: sum of 3 quarters · filed 2016-02-29 | $26.45M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-03-31 | $9.11M 10-Q · filed 2015-05-05 | $16.70M derived: sum of 2 quarters · filed 2016-02-29 | $17.23M derived: sum of 3 quarters · filed 2016-02-29 | $17.83M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2013-12-31 | $7.59M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $8.12M derived: sum of 2 quarters · filed 2016-02-29 | $8.72M derived: sum of 3 quarters · filed 2016-02-29 | $10.45M 10-K · filed 2016-02-29 | ||||
| 2013-09-30 | $526.00K 10-Q · filed 2014-10-28 | $1.13M derived: sum of 2 quarters · filed 2014-10-28 | $2.85M 10-Q · filed 2014-10-28 | $4.78M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2013-06-30 | $603.00K 10-Q · filed 2014-07-31 | $2.33M 10-Q · filed 2014-07-31 | $4.26M derived: sum of 3 quarters · filed 2015-03-02 | $6.09M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2013-03-31 | $1.73M 10-Q · filed 2014-05-02 | $3.65M derived: sum of 2 quarters · filed 2015-03-02 | $5.49M derived: sum of 3 quarters · filed 2015-03-02 | $7.42M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2012-12-31 | $1.93M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $3.77M derived: sum of 2 quarters · filed 2015-03-02 | $5.69M derived: sum of 3 quarters · filed 2015-03-02 | $7.64M 10-K · filed 2015-03-02 | ||||
| 2012-09-30 | $1.84M 10-Q · filed 2013-10-28 | $3.76M derived: sum of 2 quarters · filed 2013-10-28 | $5.71M 10-Q · filed 2013-10-28 | $7.59M derived: sum of 4 quarters · filed 2014-02-26 | ||||
| 2012-06-30 | $1.93M 10-Q · filed 2013-07-29 | $3.87M 10-Q · filed 2013-07-29 | $5.75M derived: sum of 3 quarters · filed 2014-02-26 | $7.92M derived: sum of 4 quarters · filed 2014-02-26 | ||||
| 2012-03-31 | $1.95M 10-Q · filed 2013-04-29 | $3.83M derived: sum of 2 quarters · filed 2014-02-26 | $5.99M derived: sum of 3 quarters · filed 2014-02-26 | $8.19M derived: sum of 4 quarters · filed 2014-02-26 | ||||
| 2011-12-31 | $1.88M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-26 | $4.05M derived: sum of 2 quarters · filed 2014-02-26 | $6.25M derived: sum of 3 quarters · filed 2014-02-26 | $8.41M 10-K · filed 2014-02-26 | $8.35M 10-K · filed 2012-02-22 | |||
| 2011-09-30 | $2.17M 10-Q · filed 2012-10-29 | $2.43M 10-Q · filed 2011-10-31 | $4.37M derived: sum of 2 quarters · filed 2012-10-29 | $6.53M 10-Q · filed 2012-10-29 | $6.64M 10-Q · filed 2011-10-31 | $9.28M derived: sum of 4 quarters · filed 2013-02-26 | ||
| 2011-06-30 | $2.20M 10-Q · filed 2012-08-02 | $2.07M 10-Q · filed 2011-08-01 | $4.36M 10-Q · filed 2012-08-02 | $4.21M 10-Q · filed 2011-08-01 | $7.11M derived: sum of 3 quarters · filed 2013-02-26 | $10.12M derived: sum of 4 quarters · filed 2013-02-26 | ||
| 2011-03-31 | $2.16M 10-Q · filed 2012-04-30 | $2.14M 10-Q · filed 2011-04-29 | $4.91M derived: sum of 2 quarters · filed 2013-02-26 | $7.92M derived: sum of 3 quarters · filed 2013-02-26 | $10.55M derived: sum of 4 quarters · filed 2013-02-26 | |||
| 2010-12-31 | $2.75M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $5.75M derived: sum of 2 quarters · filed 2013-02-26 | $8.39M derived: sum of 3 quarters · filed 2013-02-26 | $10.82M 10-K · filed 2013-02-26 | $10.33M 10-K · filed 2011-02-24 | |||
| 2010-09-30 | $3.01M 10-Q · filed 2011-10-31 | $5.64M derived: sum of 2 quarters · filed 2011-10-31 | $8.07M 10-Q · filed 2011-10-31 | $10.79M derived: sum of 4 quarters · filed 2012-02-22 | ||||
| 2010-06-30 | $2.63M 10-Q · filed 2011-08-01 | $5.06M 10-Q · filed 2011-08-01 | $7.78M derived: sum of 3 quarters · filed 2012-02-22 | $10.66M derived: sum of 4 quarters · filed 2012-02-22 | ||||
| 2010-03-31 | $2.43M 10-Q · filed 2011-04-29 | $5.14M derived: sum of 2 quarters · filed 2012-02-22 | $8.02M derived: sum of 3 quarters · filed 2012-02-22 | $12.43M derived: sum of 4 quarters · filed 2012-02-22 | ||||
| 2009-12-31 | $2.71M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | $5.59M derived: sum of 2 quarters · filed 2012-02-22 | $10.00M derived: sum of 3 quarters · filed 2012-02-22 | $14.09M 10-K · filed 2012-02-22 | ||||
| 2009-09-30 | $2.88M 10-Q · filed 2010-10-29 | $7.28M derived: sum of 2 quarters · filed 2010-10-29 | $11.38M 10-Q · filed 2010-10-29 | |||||
| 2009-06-30 | $4.40M 10-Q · filed 2010-08-04 | $8.50M 10-Q · filed 2010-08-04 | ||||||
| 2008-12-31 | $16.39M 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |